Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-03

Clinical Trial Update: Binge Eating and Chromium Study [Phase 1, Phase 2]

View source ↗

Summary

This record notes completion of a Phase 1/Phase 2 clinical trial evaluating chromium supplementation for binge eating disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chromium (Chromium)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Binge Eating Disorder | Phase 1, Phase 2 | Status: COMPLETED